| 000 | 01983cam a22004818a 4500 | ||
|---|---|---|---|
| 005 | 20250918122351.0 | ||
| 006 | m d | ||
| 007 | cr | ||
| 008 | 100819s2009 pau sb 001 0 eng | ||
| 010 | _a2008-000008 | ||
| 020 | _a9780781774246 (alk. paper) | ||
| 020 | _a9781469867519 (electronic bk.) | ||
| 020 | _a0781774241 (alk. paper) | ||
| 035 | _a(DNLM)101462649 | ||
| 035 | _a2008000008(DLC) | ||
| 035 | _a(DLC)B000001770 | ||
| 039 | 9 |
_y08-19-2010 _znona |
|
| 040 |
_aDNLM/DLC _cDLC _dDLC |
||
| 050 | 0 | 0 |
_aRM301.25 _b.S693 2009 |
| 060 | 1 | 0 |
_aQV 744 _bS756g 2009 |
| 082 | 0 | 0 |
_a615/.19 _222 |
| 090 | _aebook PHCTM | ||
| 100 | 1 | _aSpilker, Bert. | |
| 245 | 1 | 0 |
_aGuide to drug development _h[electronic resource] : _ba comprehensive review & assessment / _cBert Spilker. |
| 260 |
_aPhiladelphia : _bWolters Kluwer/Lippincott Williams & Wilkins Health, _cc2009. |
||
| 263 | _a0807 | ||
| 300 |
_ap. ; _ccm. |
||
| 504 | _aIncludes bibliographical references and index. | ||
| 533 |
_aElectronic reproduction. _bNew York, N.Y. : _cOvid Technologies, Inc. _nAvailable via World Wide Web. |
||
| 650 | 0 | _aDrug development. | |
| 650 | 1 | 2 | _aDrug Design. |
| 650 | 2 | 2 |
_aDrug Evaluation, Preclinical _xmethods. |
| 650 | 2 | 2 |
_aDrug Industry _xmethods. |
| 650 | 2 | 2 | _aPharmaceutical preparations. |
| 710 | 2 | _aOvid Technologies, Inc. | |
| 856 | 4 | 0 |
_aE-Books (Ovid) _zAuthentication may be required: _uhttps://eresourcesptsl.ukm.remotexs.co/login?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=booktext&NEWS=N&DF=bookdb&AN=01337530/1st_Edition&XPATH=/PG(0) |
| 856 | 4 | 0 | _uhttps://ukmy-ovidds-com.eresourcesptsl.ukm.remotexs.co/discover/result?logSearchID=125256219&pubid=7428-tdkb%3A498901&pubid=1023-ovid-books-open%3AB01337530-M1&pubid=7176-nlmcat%3A101462649 |
| 907 |
_a.b14795073 _b2023-06-27 _c2019-11-12 |
||
| 942 |
_n0 _kebook PHCTM |
||
| 914 | _avtls003440709 | ||
| 998 |
_ah _b2010-06-08 _cm _dz _feng _gpau _y0 _z.b14795073 |
||
| 999 |
_c466239 _d466239 |
||